BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 37878205)

  • 1. Defining new biomarkers for overcoming therapeutical resistance in cervical cancer using lncRNA.
    Aswathy R; Sumathi S
    Mol Biol Rep; 2023 Dec; 50(12):10445-10460. PubMed ID: 37878205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive analysis of lncRNA-mRNA co-expression networks in HPV-driven cervical cancer reveals the pivotal function of LINC00511-PGK1 in tumorigenesis.
    Xin X; Jia-Yin Y; Jun-Yang H; Rui W; Xiong-Ri K; Long-Rui D; Liu J; Jue-Yu Z
    Comput Biol Med; 2023 Jun; 159():106943. PubMed ID: 37099974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long non-coding RNAs and cervical cancer.
    Aalijahan H; Ghorbian S
    Exp Mol Pathol; 2019 Feb; 106():7-16. PubMed ID: 30471246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypomethylation of the lncRNA SOX21-AS1 has clinical prognostic value in cervical cancer.
    Wang R; Li Y; Du P; Zhang X; Li X; Cheng G
    Life Sci; 2019 Sep; 233():116708. PubMed ID: 31369759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long noncoding RNAs in cervical cancer.
    Shi D; Zhang C; Liu X
    J Cancer Res Ther; 2018; 14(4):745-753. PubMed ID: 29970647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of long non-coding RNA expression profiles in lymph node metastasis of early-stage cervical cancer.
    Shang C; Zhu W; Liu T; Wang W; Huang G; Huang J; Zhao P; Zhao Y; Yao S
    Oncol Rep; 2016 Jun; 35(6):3185-97. PubMed ID: 27035672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNAs: key players and novel insights into cervical cancer.
    Peng L; Yuan X; Jiang B; Tang Z; Li GC
    Tumour Biol; 2016 Mar; 37(3):2779-88. PubMed ID: 26715267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potentials of lncRNA-miRNA-mRNA networks as biomarkers for laryngeal squamous cell carcinoma.
    Lv Y; Wang Y; Zhang Z
    Hum Cell; 2023 Jan; 36(1):76-97. PubMed ID: 36181662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long noncoding RNAs (lncRNAs) in cervical carcinogenesis: New molecular targets, current prospects.
    Galvão MLTC; Coimbra EC
    Crit Rev Oncol Hematol; 2020 Dec; 156():103111. PubMed ID: 33080526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive analysis of aberrantly expressed long non‑coding RNAs, microRNAs, and mRNAs associated with the competitive endogenous RNA network in cervical cancer.
    Chen P; Zhang W; Chen Y; Zheng X; Yang D
    Mol Med Rep; 2020 Jul; 22(1):405-415. PubMed ID: 32377727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Roles of long non-coding RNAs in cervical cancer.
    Luo F; Wen Y; Zhou H; Li Z
    Life Sci; 2020 Sep; 256():117981. PubMed ID: 32561395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long Noncoding RNA HOTAIR: An Oncogene in Human Cervical Cancer Interacting With MicroRNA-17-5p.
    Ji F; Wuerkenbieke D; He Y; Ding Y; Du R
    Oncol Res; 2018 Apr; 26(3):353-361. PubMed ID: 28745272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long Noncoding RNA ANRIL Promotes Cervical Cancer Development by Acting as a Sponge of miR-186.
    Zhang JJ; Wang DD; Du CX; Wang Y
    Oncol Res; 2018 Apr; 26(3):345-352. PubMed ID: 28550682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long non-coding RNA, steroid receptor RNA activator (SRA), induces tumor proliferation and invasion through the NOTCH pathway in cervical cancer cell lines.
    Eoh KJ; Paek J; Kim SW; Kim HJ; Lee HY; Lee SK; Kim YT
    Oncol Rep; 2017 Dec; 38(6):3481-3488. PubMed ID: 29039612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Up-regulated BCAR4 contributes to proliferation and migration of cervical cancer cells.
    Zou R; Chen X; Jin X; Li S; Ou R; Xue J; Yan X; Chen L; Hu Y; Zhu H
    Surg Oncol; 2018 Jun; 27(2):306-313. PubMed ID: 29937186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Up-regulation of inflammation-related LncRNA-IL7R predicts poor clinical outcome in patients with cervical cancer.
    Fan Y; Nan Y; Huang J; Zhong H; Zhou W
    Biosci Rep; 2018 Jun; 38(3):. PubMed ID: 29720427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long non-coding RNAs on the stage of cervical cancer (Review).
    Dong J; Su M; Chang W; Zhang K; Wu S; Xu T
    Oncol Rep; 2017 Oct; 38(4):1923-1931. PubMed ID: 28849103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dysregulated LncRNAs Act as Competitive Endogenous RNAs and Are Associated With Cervical Cancer Development in UYGHUR Women.
    Chen Y; Chen D; Wang J; Zhang Y; Zhang J; Chen B; Chen Y; Zhang Y; Ma C
    Technol Cancer Res Treat; 2021; 20():1533033821989711. PubMed ID: 33596784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive analysis of lncRNAs microarray profile and mRNA-lncRNA co-expression in oncogenic HPV-positive cervical cancer cell lines.
    Yang L; Yi K; Wang H; Zhao Y; Xi M
    Oncotarget; 2016 Aug; 7(31):49917-49929. PubMed ID: 27363024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long non-coding RNAs as critical regulators and novel targets in cervical cancer: current status and future perspectives.
    Ranga S; Yadav R; Chhabra R; Chauhan MB; Tanwar M; Yadav C; Kadian L; Ahuja P
    Apoptosis; 2023 Aug; 28(7-8):925-942. PubMed ID: 37095313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.